RHRalf Heinrich

Ralf Heinrich

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ralf Heinrich has a total of 76 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Multiple Mammalian Cytokines and Erythropoietin‐Mimetic Peptides Protect Insect Neurons via Phylogenetically Conserved Cytokine Receptor‐Like Factor 3 ( CRLF3 )

    by Nina Hahn, Debbra Y. Knorr, Björn Twellsieck, Ruoyu Huang, Abigail Trebilcock, Nicola Schwedhelm‐Domeyer, Stephanie Pauls, Lars V. Werven, Olaf Jahn, Hannelore Ehrenreich, et al.

    Erythropoietin (Epo) and its non‐erythropoietic splice variant EV‐3 have demonstrated potent neuroprotective effects across species, although the respective mechanisms are variable and incompletely understood. Unlike vertebrates, insects lack both Epo and the classical Epo receptor but express Cytokine Receptor‐Like Factor 3 (CRLF3), a conserved type I receptor that serves as a neuroprotective receptor for Epo and EV‐3 in insects and human iPSC‐derived neuron‐like cells. Insects, which express CRLF3 but lack all other group 1 type I cytokine receptors, represent a suitable model to study the function of CRLF3 in neuroprotection. Previous experiments with primary brain neurons from the locust Locusta migratoria demonstrated that human Epo and EV‐3 prevented hypoxia‐induced apoptosis via activation of CRLF3 and downstream signaling mediated by JAK/STAT activity. Here we demonstrate that locust neurons are also protected by three small peptides (≤ 20 amino acids) with previously established erythropoietic and/or neuroprotective capacities in mammals. These peptides included non‐erythropoietic HBSP and P16, as well as erythropoietic EMP1. To further characterize the ligand spectrum of locust CRLF3, we tested specific ligands of vertebrate group 1 type I cytokine receptors for their neuroprotective potential. While human thrombopoietin protected locust neurons via activation of CRLF3, human prolactin and growth hormone showed no anti‐apoptotic effects. Our findings highlight CRLF3 as a versatile neuroprotective receptor that can be activated by the three natural human cytokines Epo, EV‐3, and thrombopoietin, and three artificial short peptides with and without erythropoietic activity. In contrast to vertebrate classical Epo receptor, which is only activated by Epo and EMP1, CRLF3 has an extended and more generalist ligand spectrum to mediate neuroprotection. This wide ligand spectrum may support the hypothesis of CRLF3 being the evolutionary precursor of various vertebrate‐specific cytokine receptors and may qualify this more general cell protective receptor as a target for pharmacological intervention in neurodegenerative processes. image


  • Open Access

    Multifaceted promotion of apoptosis by acetylcholinesterase

    by Debbra Y. Knorr, Defne Demirbas, Ralf Heinrich

    Elevated expression of acetylcholinesterase (AChE) is a common characteristic of apoptotic cells in both invertebrate and vertebrate species. While increased levels of acetylcholinesterase sensitize cells to apoptogenic stimuli, its absence or pharmacological inactivation interferes with apoptotic cell death. acetylcholinesterase may exert its pro-apoptotic function directly as an integral component of the apoptotic molecular machinery or indirectly by limiting the availability of receptor ligands and structural binding partners that promote cell survival under non-apoptogenic conditions. acetylcholinesterase promotes formation of the apoptosome and degrades DNA after nuclear accumulation. Its esterase activity limits the availability of acetylcholine as ligand for cell membrane-located nicotinic and muscarinic ACh-receptors and mitochondrial nicotinic ACh-receptors that normally support vital physiological states. Studies on insects suggest, that cytokine-activated cell-protective pathways may suppress acetylcholinesterase overexpression under apoptogenic conditions to prevent apoptotic cell death. We provide an overview of studies on various organisms and cell types that summarizes the contribution of acetylcholinesterase to the progress of apoptosis via multiple mechanisms.


  • Open Access

    The cytokine receptor CRLF3 is a human neuroprotective EV-3 (Epo) receptor

    by Debbra Y. Knorr, Ignacio Rodriguez Polo, Hanna S. Pies, Nicola Schwedhelm-Domeyer, Stephanie Pauls, Rüdiger Behr, Ralf Heinrich

    The evolutionary conserved orphan cytokine receptor-like factor 3 (CRLF3) has been implicated in human disease, vertebrate hematopoiesis and insect neuroprotection. While its specific functions are elusive, experimental evidence points toward a general role in cell homeostasis. Erythropoietin (Epo) is a major regulator of vertebrate hematopoiesis and a general cytoprotective cytokine. Erythropoietic functions mediated by classical Epo receptor are understood in great detail whereas Epo-mediated cytoprotective mechanisms are more complex due to involvement of additional Epo receptors and a non-erythropoietic splice variant with selectivity for certain receptors. In the present study, we show that the human CRLF3 mediates neuroprotection upon activation with the natural Epo splice variant EV-3. We generated CRLF3 knock-out iPSC lines and differentiated them toward the neuronal lineage. While apoptotic death of rotenone-challenged wild type iPSC-derived neurons was prevented by EV-3, EV-3-mediated neuroprotection was absent in CRLF3 knock-out neurons. Rotenone-induced apoptosis and EV-3-mediated neuroprotection were associated with differential expression of pro-and anti-apoptotic genes. Our data characterize human CRLF3 as a receptor involved in Epo-mediated neuroprotection and identify CRLF3 as the first known receptor for EV-3.


  • Open Access

    Protection of insect neurons by erythropoietin/CRLF3-mediated regulation of pro-apoptotic acetylcholinesterase

    by Debbra Y. Knorr, Kristin Schneider, Luca Büschgens, Jan Förster, Nadine S. Georges, Bart R. H. Geurten, Ralf Heinrich

    Cytokine receptor-like factor 3 (CRLF3) is a conserved but largely uncharacterized orphan cytokine receptor of eumetazoan animals. CRLF3-mediated neuroprotection in insects can be stimulated with human erythropoietin. To identify mechanisms of CRLF3-mediated neuroprotection we studied the expression and proapoptotic function of acetylcholinesterase in insect neurons. We exposed primary brain neurons from Tribolium castaneum to apoptogenic stimuli and dsRNA to interfere with acetylcholinesterase gene expression and compared survival and acetylcholinesterase expression in the presence or absence of the CRLF3 ligand erythropoietin. Hypoxia increased apoptotic cell death and expression of both acetylcholinesterase-coding genes ace-1 and ace-2. Both ace genes give rise to single transcripts in normal and apoptogenic conditions. Pharmacological inhibition of acetylcholinesterases and RNAi-mediated knockdown of either ace-1 or ace-2 expression prevented hypoxia-induced apoptosis. Activation of CRLF3 with protective concentrations of erythropoietin prevented the increased expression of acetylcholinesterase with larger impact on ace-1 than on ace-2. In contrast, high concentrations of erythropoietin that cause neuronal death induced ace-1 expression and hence promoted apoptosis. Our study confirms the general proapoptotic function of AChE, assigns a role of both ace-1 and ace-2 in the regulation of apoptotic death and identifies the erythropoietin/CRLF3-mediated prevention of enhanced acetylcholinesterase expression under apoptogenic conditions as neuroprotective mechanism.


  • Open Access

    Human cytokine receptor CRLF3 is a receptor for the neuroprotective erythropoietin splice variant EV-3

    by Debbra Y Knorr, Ignacio Rodriguez Polo, Hanna S Pies, Nicola Schwedhelm-Domeyer, Stephanie Pauls, Rüdiger Behr, Ralf Heinrich

    Cytokine receptor like factor 3 (CRLF3) is a conserved cytokine receptor present in all major eumetazoan taxa. Though vertebrate CRLF3 has recently been implied in the regulation of hematopoiesis, its ligand remained unidentified. CRLF3 shares structural similarity with receptors for other hematopoietic growth factors including erythropoietin, thrombopoietin and granulocyte colony-stimulating factor. Besides hematopoietic organs, these established hematopoietic cytokines and their receptors are also widely expressed in other tissues including the nervous system, where they regulate proliferation, differentiation, cell survival and other homeostatic processes. Previous studies identified insect CRLF3 as a neuroprotective receptor that can be activated by human recombinant erythropoietin, a widely accepted protective cytokine in vertebrate nervous systems. Epo’s erythropoietic functions mediated by classical Epo receptor are understood in great detail whereas Epo-mediated cytoprotective mechanisms are more complex due to involvement of additional Epo receptors and a splice variant (EV-3) with selectivity for certain unidentified receptors. In the present study, we show that human CRLF3 mediates neuroprotection upon activation with the natural Epo splice variant EV-3. We generated CRLF3 knock out iPSC lines and differentiated them towards the neuronal lineage. While apoptotic death of rotenone-challenged wild type iPSC-derived neurons was prevented by EV-3, EV-3-mediated neuroprotection was absent in CRLF3 knock out neurons. Rotenone-induced apoptosis and EV-3-mediated neuroprotection were associated with differential expression of pro- and anti-apoptotic genes. Our data characterize human CRLF3 as a receptor involved in Epo-mediated neuroprotection and identify CRLF3 as the first known receptor for EV-3.

  • Open Access

    Protection of insect neurons by erythropoietin/CRLF3-mediated regulation of pro-apoptotic acetylcholinesterase

    by Debbra Y. Knorr, Kristin Schneider, Luca Büschgens, Jan Förster, Nadine S. Georges, Bart R.H. Geurten, Ralf Heinrich

    Cytokine receptor-like factor 3 (CRLF3) is a highly conserved but largely uncharacterized orphan cytokine receptor that shares structural similarity with vertebrate classical erythropoietin receptor. CRLF3-mediated neuroprotection in insects can be stimulated with human erythropoietin and involves partly similar anti-apoptotic mechanisms as erythropoietin-mediated neuroprotection in mammals. To identify potential mechanisms of CRLF3-mediated neuroprotection we studied the expression and function of acetylcholinesterase which promotes apoptosis in different cell types, including mammalian neurons. We exposed primary brain neurons from Locusta migratoria and Tribolium castaneum to apoptogenic stimuli and/or dsRNA to interfere with acetylcholinesterase gene expression and compared survival and/or acetylcholinesterase expression in the presence or absence of the CRLF3 ligand erythropoietin. Hypoxia increases both apoptotic cell death and expression of both acetylcholinesterase-coding genes ace-1 and ace-2. Both ace genes give rise to single transcripts in both normal and apoptogenic condictions. Pharmacological inhibition of both acetylcholinesterases and RNAi-mediated knockdown of either ace-1 or ace-2 expression prevent hypoxia-induced apoptosis of primary brain neurons. Activation of CRLF3 with protective concentrations of rhEpo prevents the increased expression of pro-apoptotic acetylcholinesterase with larger impact on ace-1 than on ace-2. In contrast, high concentrations of rhEpo that commonly (and seemingly paradoxically) cause death of insect and mammalian neurons induced ace-1 expression and hence promoted apoptosis in insect neurons. Our study confirms the cell-intrinsic role of acetylcholinesterase as a major regulator of apoptotic death, that was previously described in mammalian neurons only. Moreover, we identify a mechanism (prevention of upregulation of pro-apoptotic acetylcholinesterase), by which CRLF3 activation mediates neuroprotection under apoptogenic conditions. Since both apoptosis and CRLF3 are conserved throughout the animal kingdom, the direct link between cytokine/CRLF3 activation and suppression of increased acetylcholinesterase expression underlying neuroprotection in insects may also be present in other cell types and other non-insect species.

  • Open Access

    Locust Hemolymph Conveys Erythropoietin-Like Cytoprotection via Activation of the Cytokine Receptor CRLF3

    by Debbra Y. Knorr, Denise Hartung, Kristin Schneider, Luzia Hintz, Hanna S. Pies, Ralf Heinrich

    The cytokine receptor-like factor 3 (CRLF3) is an evolutionary conserved class 1 cytokine receptor present in all major eumetazoan groups. Endogenous CRLF3 ligands have not been identified and the physiological responses mediated by mammalian CRLF3 are poorly characterized. Insect CRLF3 is activated by erythropoietin (Epo) and several related molecules that protect mammalian neurons from stress-induced apoptosis. However, insects neither express Epo nor “classical” Epo receptor. Cell-protective effects of insect hemolymph have been described for several species. In this study, we explored the possibility that the endogenous CRLF3 ligand is contained in locust hemolymph. PCR analyses confirmed expression ofcrfl3-transcripts in neurons and hemocytes ofLocusta migratoriaandTribolium castaneum. Survival of locust hemocytes in primary cultures was significantly increased by supplementation of culture medium with locust hemolymph serum. Locust primary neuron cultures were also protected by locust hemolymph, though preceding exposure to fetal bovine serum changed the hemolymph dose-dependency of neuroprotection. Direct comparison of 10% hemolymph serum with recombinant human Epo in its optimal neuroprotective concentration revealed equivalent anti-apoptotic effects on hypoxia-exposed locust neurons. The same concentration of locust hemolymph serum also protected hypoxia-exposedT. castaneumneurons. This indicates that the neuroprotective factor in locust hemolymph is sufficiently conserved in insects to allow activation of neuroprotective receptors in different species. Locust hemolymph-induced neuroprotection in bothL. migratoriaandT. castaneumwas abolished after RNAi-mediated suppression ofcrlf3-expression. In summary, we report the presence of a conserved endogenous cytokine in locust hemolymph that activates CRLF3 and connected anti-apoptotic processes in hemocytes and neurons. Identification and characterization of the CRLF3 ligand will promote knowledge about cytokine evolution and may unravel cell-protective agents with potential clinical application.


  • Open Access

    Acetylcholinesterase promotes apoptosis in insect neurons

    by Debbra Y. Knorr, Nadine S. Georges, Stephanie Pauls, Ralf Heinrich

    Apoptosis plays a major role in development, tissue renewal and the progression of degenerative diseases. Studies on various types of mammalian cells reported a pro-apoptotic function of acetylcholinesterase (AChE), particularly in the formation of the apoptosome and the degradation of nuclear DNA. While three AChE splice variants are present in mammals, invertebrates typically express twoachegenes that code for a synaptically located protein and a protein with non-synaptic functions respectively. In order to investigate a potential contribution of AChE to apoptosis in insects, we selected the migratory locustLocusta migratoria.We established primary neuronal cultures of locust brains and characterized apoptosis progression in vitro. Dying neurons displayed typical characteristics of apoptosis, including caspase-activation, nuclear condensation and DNA fragmentation visualized by TUNEL staining. Addition of the AChE inhibitors neostigmine and territrem B reduced apoptotic cell death under normal culture conditions. Moreover, both inhibitors completely suppressed hypoxia-induced neuronal cell death. Exposure of live animals to severe hypoxia moderately increased the expression oface-1in locust brains in vivo. Our results indicate a previously unreported role of AChE in insect apoptosis that parallels the pro-apoptotic role in mammalian cells. This similarity adds to the list of apoptotic mechanisms shared by mammals and insects, supporting the hypothesized existence of an ancient, complex apoptosis regulatory network present in common ancestors of vertebrates and insects.


  • Open Access

    The Orphan Cytokine Receptor CRLF3 Emerged With the Origin of the Nervous System and Is a Neuroprotective Erythropoietin Receptor in Locusts

    by Nina Hahn, Luca Büschgens, Nicola Schwedhelm-Domeyer, Sarah Bank, Bart R. H. Geurten, Pia Neugebauer, Bita Massih, Martin C. Göpfert, Ralf Heinrich

    The orphan cytokine receptor-like factor 3 (CRLF3) was identified as a neuroprotective erythropoietin receptor in locust neurons and emerged with the evolution of the eumetazoan nervous system. Human CRLF3 belongs to class I helical cytokine receptors that mediate pleiotropic cellular reactions to injury and diverse physiological challenges. It is expressed in various tissues including the central nervous system but its ligand remains unidentified. A CRLF3 ortholog in the holometabolous beetle Tribolium castaneum was recently shown to induce anti-apoptotic mechanisms upon stimulation with human recombinant erythropoietin. To test the hypothesis that CRLF3 represents an ancient cell-protective receptor for erythropoietin-like cytokines, we investigated its presence across metazoan species. Furthermore, we examined CRLF3 expression and function in the hemimetabolous insect Locusta migratoria. Phylogenetic analysis of CRLF3 sequences indicated that CRLF3 is absent in Porifera, Placozoa and Ctenophora, all lacking the traditional nervous system. However, it is present in all major eumetazoan groups ranging from cnidarians over protostomians to mammals. The CRLF3 sequence is highly conserved and abundant amongst vertebrates. In contrast, relatively few invertebrates express CRLF3 and these sequences show greater variability, suggesting frequent loss due to low functional importance. In L. migratoria, we identified the transcript Lm-crlf3 by RACE-PCR and detected its expression in locust brain, skeletal muscle and hemocytes. These findings correspond to the ubiquitous expression of crlf3 in mammalian tissues. We demonstrate that the sole addition of double-stranded RNA to the culture medium (called soaking RNA interference) specifically interferes with protein expression in locust primary brain cell cultures. This technique was used to knock down Lm-crlf3 expression and to abolish its physiological function. We confirmed that recombinant human erythropoietin rescues locust brain neurons from hypoxia-induced apoptosis and showed that this neuroprotective effect is absent after knocking down Lm-crlf3. Our results affirm the erythropoietin-induced neuroprotective function of CRLF3 in a second insect species from a different taxonomic group. They suggest that the phylogenetically conserved CRLF3 receptor may function as a cell protective receptor for erythropoietin or a structurally related cytokine also in other animals including vertebrate and mammalian species.


  • Open Access

    Alternative Erythropoietin Receptors in the Nervous System

    by Daniela Ostrowski, Ralf Heinrich

    In addition to its regulatory function in the formation of red blood cells (erythropoiesis) in vertebrates, Erythropoietin (Epo) contributes to beneficial functions in a variety of non-hematopoietic tissues including the nervous system. Epo protects cells from apoptosis, reduces inflammatory responses and supports re-establishment of compromised functions by stimulating proliferation, migration and differentiation to compensate for lost or injured cells. Similar neuroprotective and regenerative functions of Epo have been described in the nervous systems of both vertebrates and invertebrates, indicating that tissue-protective Epo-like signaling has evolved prior to its erythropoietic function in the vertebrate lineage. Epo mediates its erythropoietic function through a homodimeric Epo receptor (EpoR) that is also widely expressed in the nervous system. However, identification of neuroprotective but non-erythropoietic Epo splice variants and Epo derivatives indicated the existence of other types of Epo receptors. In this review, we summarize evidence for potential Epo receptors that might mediate Epo’s tissue-protective function in non-hematopoietic tissue, with focus on the nervous system. In particular, besides EpoR, we discuss three other potential neuroprotective Epo receptors: (1) a heteroreceptor consisting of EpoR and common beta receptor (βcR), (2) the Ephrin (Eph) B4 receptor and (3) the human orphan cytokine receptor-like factor 3 (CRLF3).